Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Solutions (RSSS) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Research Solutions (RSSS) over the last 15 years, with Q4 2025 value amounting to $9.9 million.

  • Research Solutions' Current Deferred Revenue rose 1201.16% to $9.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.9 million, marking a year-over-year increase of 1201.16%. This contributed to the annual value of $10.7 million for FY2025, which is 1859.82% up from last year.
  • Latest data reveals that Research Solutions reported Current Deferred Revenue of $9.9 million as of Q4 2025, which was up 1201.16% from $10.0 million recorded in Q3 2025.
  • Over the past 5 years, Research Solutions' Current Deferred Revenue peaked at $10.7 million during Q2 2025, and registered a low of $4.4 million during Q3 2021.
  • Moreover, its 5-year median value for Current Deferred Revenue was $6.5 million (2023), whereas its average is $7.2 million.
  • In the last 5 years, Research Solutions' Current Deferred Revenue skyrocketed by 811.15% in 2021 and then skyrocketed by 4045.5% in 2024.
  • Quarter analysis of 5 years shows Research Solutions' Current Deferred Revenue stood at $4.7 million in 2021, then increased by 25.86% to $6.0 million in 2022, then surged by 31.44% to $7.8 million in 2023, then rose by 12.87% to $8.9 million in 2024, then rose by 12.01% to $9.9 million in 2025.
  • Its last three reported values are $9.9 million in Q4 2025, $10.0 million for Q3 2025, and $10.7 million during Q2 2025.